Consultant, Medical Oncology
Adelaide Medical School
Faculty of Health and Medical Sciences
Dr Rohit Joshi MBBS MD FRACP FACP
Dr Rohit Joshi works as a Medical Oncology Consultant with Adelaide Oncology and Haematology (at Calvary Central Districts Hospital and Calvary North Adelaide Hospital). He also works at the Northern Adelaide Cancer Centre at the Lyell McEwin Hospital. Rohit is actively involved in the teaching of under-graduate and post-graduate students as a Clinical Lecturer at the University of Adelaide.
He completed his undergraduate and postgraduate training at the Christian Medical College in India, after which he trained in Medical Oncology at the Royal Adelaide Hospital. He also gained European Certification in Medical Oncology in 2012.
Rohit is the Director of Cancer Research and Clinical Trials at Adelaide Oncology and Haematology. He was the former Director of Cancer Research and Clinical Trials at the Lyell McEwin Hospital. His main research interests include clinical trials and new drugs therapies in lung, colorectal, breast and genitourinary cancers, along with supportive and palliative care studies.
Rohit treats all solid cancer types with major interests in lung, colorectal, pancreatic, renal, melanoma and breast cancers
Date Position Institution name 2018 Director, Cancer Research and Clinical Trials Adelaide Oncology and Haematology 2014 Consultant, Medical Oncology Adelaide Oncology and Haematology 2013 - 2017 Director, Cancer Research and Clinical Trials SA Health - Lyell McEwin Hospital 2013 Consultant SA Health - Lyell McEwin Hospital 2010 Clinical Lecturer University of Adelaide 2008 - 2010 Assistant Professor Christian Medical College
Language Competency English Can read, write, speak, understand spoken and peer review Hindi Can read, write, speak and understand spoken Panjabi; Punjabi Can read, write, speak and understand spoken
Date Institution name Country Title 2015 American College of Physicians USA FACP 2013 Royal Adelaide and Lyell McEwin Hospitals Australia FRACP 1999 - 2002 Christian Medical College India MD 1991 - 1996 Christian Medical College India MBBS
Date Title Institution name Country 2012 European Certified Medical Oncologist (ECMO) European Society of Medical Oncology Switzerland
Year Citation 2017 Townsend, A. R., Hardingham, J., Tebbutt, N. C., Karapetis, C. S., Singhal, N., Joshi, R., . . . Price, T. J. (2017). A phase Ib/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT): Biomarker substudy.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. 2015 Patel, D., Abdghan, N., Kerr, K. -A., Row, J., Adams, J., & Joshi, R. (2015). Clinical presentation and management pattern of venous thrombosis in patients receiving chemotherapy. In ANNALS OF ONCOLOGY Vol. 26 (pp. 116-117). Singapore, SINGAPORE: OXFORD UNIV PRESS. 2007 Joshi, R., O'Neill, S., & Keefe, D. (2007). A prospective audit of inpatient medical oncology consultation patterns in a tertiary teaching hospital in South Australia. In ANNALS OF ONCOLOGY Vol. 18 (pp. 196-197). Lugano, SWITZERLAND: OXFORD UNIV PRESS.
Year Citation 2018 Telli, M., Wapnir, I., Vinayak, S., Soliman, H., Cuff, K., Devitt, B., . . . Joshi, R. (2018). A phase 2 study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation with pembrolizumab in patients with inoperable locally advanced or metastatic triple-negative breast cancer. Poster session presented at the meeting of San Antonio Breast Cancer Symposium. San Antonio, Texas. 2016 Doherty, T., Hislop, C., Fitzgerald, M., Campbell, J., Poprawski, D., Roberts, S., . . . Koczwara, B. (2016). CONTEXT IMPACTS OUTCOMES: LESSONS LEARNT FROM THE SOUTH AUSTRALIAN SURVIVORSHIP FRAMEWORK PILOT IMPLEMENTATION. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2016 Townsend, A., Tebbutt, N., Karapetis, C., Cooper, P., Singhal, N., Yeend, S., . . . Price, T. (2016). A phase IB/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT). Poster session presented at the meeting of ANNALS OF ONCOLOGY. Copenhagen, DENMARK: OXFORD UNIV PRESS.
2016 Joshi, R., Connolly, P., Foo, T., & Rowe, J. (2016). Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy. Poster session presented at the meeting of ANNALS OF ONCOLOGY. OXFORD UNIV PRESS. 2013 Vatandoust, S., Joshi, R., Pittman, K., Esterman, A., Broadbridge, V., Adams, J., . . . Price, T. (2013). A descriptive study of persistent oxaliplatin induced peripheral neuropathy in patients with colorectal cancer. Poster session presented at the meeting of Abstracts of the Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Blood, Biomarkers and Beyond, 31 July - 2 August 2013, as published in Asia-Pacific Journal of Clinical Oncology. Melbourne, Victoria: Wiley-Blackwell.
2012 Grover, S., Depasquale, C., Leong, D., Cheong, K., Kotasek, D., Joshi, R., . . . Selvanayagam, J. (2012). Biventricular dysfunction following administration of anthracycline based chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. 2012 Vatandoust, S., Joshi, R., Broadbridge, V., Pittman, K. B., Adams, J., Singhal, N., . . . Price, T. J. (2012). Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: AMER SOC CLINICAL ONCOLOGY. 2011 Cheng, H. B., To, T., Joshi, R., & Singhal, N. (2011). OUTCOMES OF GERIATRIC ASSESSMENT FOR OLDER LUNG CANCER PATIENTS FROM A DEDICATED GERIATRIC ONCOLOGY PROGRAM. Poster session presented at the meeting of JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
Connect With Me